Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee

  1. Home

  • Sunday, Oct 26th
    9:00 AM - 10:00 AM Central Time
    26S14: Strength in Numbers: Using New Vaccines and Data to Protect the Immunocompromised
    Location: W190A-B
    Moderator: Amit Saxena, MD, MSc – NYU Grossman School of Medicine
    Session Coordinator: Christopher Palma, MD;RhMSUS;MSc – University of Rochester
     CE: 1.00
  • Sunday, Oct 26th
    9:00 AM - 9:30 AM Central Time
    Something New, Something Old, Something Borrowed: Optimizing Use of a Growing Portfolio of Vaccines
    Location: W190A-B
    Speaker: Olivia Kates, MD, MA – Johns Hopkins
  • Sunday, Oct 26th
    9:30 AM - 10:00 AM Central Time
    Modulating Immunomodulation: Strategie to Improve Vaccine Responses
    Location: W190A-B
    Speaker: Jin Kyun Park, MD – Seoul National University College of Medicine
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    Epidemiology & Public Health Poster I
    Location: Hall F1
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    Health Services Research Poster I
    Location: Hall F1
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    Measures & Measurement of Healthcare Quality Poster I
    Location: Hall F1
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    Patient Outcomes, Preferences, & Attitudes Poster I
    Location: Hall F1
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0145: Population Assessment of Cancer Incidence among Patients with Idiopathic Inflammatory Myopathies in North Carolina
    Location: Hall F1
    Abstract Poster Presenter: Astia Allenzara, MD, MS – University of North Carolina
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0146: Association Between Frailty and Delirium and Hospitalization Outcomes Among Older Adults with Rheumatic Diseases
    Location: Hall F1
    Abstract Poster Presenter: Bhavik Bansal, MBBS – UT Southwestern Medical Centre
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0147: Rheumatoid Arthritis prevalence estimation in France using care pathways in the National Health Data System: opportunities and limitations - PREST study
    Location: Hall F1
    Abstract Poster Presenter: Cécile Gaujoux-Viala, MD, PhD (she/her/hers) – CHU Nîmes
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0148: Air Pollution as a Trigger for Flares in Chronic Inflammatory Rheumatic Diseases: A Prospective Single-center Study in the South of France
    Location: Hall F1
    Abstract Poster Presenter: Clément VIALA, MD – Nice University Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0149: Effect Of Osteoporosis And Opioid Use On Mortality And Unplanned Healthcare Utilization Among Patients With Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Elena Myasoedova, MD, PhD – Mayo Clinic
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0150: Mortality in Anca-associated Vasculitis
    Location: Hall F1
    Abstract Poster Presenter: Fabricio Benavides, MD – Hospital Universitario Marqués de Valdecilla
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0151: Post-COVID Decline in Systemic Lupus Erythematosus Mortality in the United States: A National Analysis from 2014 to 2023
    Location: Hall F1
    Abstract Poster Presenter: Ghassan Makhoul, MD – St. Joseph's University Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0152: Exploring internet use and health information behaviour in patients with inflammatory rheumatic musculoskeletal diseases (RMD)
    Location: Hall F1
    Abstract Poster Presenter: Ioana Andreica, MD – Rheumazentrum Ruhrgebiet Herne; Ruhr-Universität Bochum, Germany
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0153: Patient Experience and Implementation of an Electronic Patient-Reported Outcome Measures (ePROM) System for Remote Monitoring in BIOBADASER
    Location: Hall F1
    Abstract Poster Presenter: Isabel Castrejon, MD, PhD (she/her/hers) – Hospital General Universitario Gregorio Marañon
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0154: Incidence and Prevalence of Connective Tissue Diseases with Interstitial Lung Disease (CTD-ILD) in the United States
    Location: Hall F1
    Abstract Poster Presenter: Keele Wurst, PhD – GSK
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0155: Effect Modification of Cigarette Smoking on the Relationship between Post Traumatic Stress Disorder and Rheumatoid Arthritis Risk
    Location: Hall F1
    Abstract Poster Presenter: Kelsey Coziahr, MD – University of Nebraska Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0156: Heat Exposure and Acute Care Utilization among Individuals with Rheumatic Conditions: A Time Series Framework for Identifying Delayed Associations
    Location: Hall F1
    Abstract Poster Presenter: Leah Santacroce, MS – Brigham and Women's Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0157: Influence of Outpatient Clinic Visits on Receipt of the COVID-19 Vaccine among People with Autoimmune Rheumatic Diseases
    Location: Hall F1
    Abstract Poster Presenter: Lesley Jackson, MD, MSPH – University of Alabama at Birmingham
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0158: Association Between Newer COVID-19 Vaccines and COVID-19 Related Hospitalizations Among People with Autoimmune Rheumatic Diseases in the U.S. National COVID Cohort Collaborative (N3C)
    Location: Hall F1
    Abstract Poster Presenter: Lesley Jackson, MD, MSPH – University of Alabama at Birmingham
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0159: Prenatal and Early-Life Environmental Exposures in Juvenile-Onset Systemic Autoimmune Rheumatic Diseases
    Location: Hall F1
    Abstract Poster Presenter: Lisa G. Rider, MD – NIEHS, NIH
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0161: Risk Factors and Clinical Predictors of Lung Cancer in Systemic Sclerosis: A Matched Case-Control Study from a Michigan Cohort
    Location: Hall F1
    Abstract Poster Presenter: Madiha Naqsh Siddiqui, MD (she/her/hers) – Michigan Medicine
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0162: Clinical Relevance of Systematic Comorbidity Screening in Autoimmune and Inflammatory Diseases
    Location: Hall F1
    Abstract Poster Presenter: Martin Michaud, MD – Clinique Saint Exupery
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0163: Trends in hospitalization and outcomes among patients admitted with Adult-onset Still's disease in the United States: INSIGHTS FROM THE NATIONAL INPATIENT SAMPLE (2016-2022)
    Location: Hall F1
    Abstract Poster Presenter: Mohammed Akram, MBBS, MD (he/him/his) – HCA Aventura
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0164: Online Patient Survey on the Impact of Extreme Weather Events on Autoimmune and Rheumatic Diseases
    Location: Hall F1
    Abstract Poster Presenter: Natasha Powell, MD – The University of Chicago Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0165: Per-Protocol Analysis of the Effectiveness of GLP1 Agonists Against SGLT2 Inhibitors on Osteoarthritis Outcomes
    Location: Hall F1
    Abstract Poster Presenter: Nene Ukonu, MS, MA – Boston University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0166: Effect of Air Pollution on Prevalence and Disease Activity of Rheumatoid Arthritis in the German Middle-aged Population from the NAKO Baseline Examination
    Location: Hall F1
    Abstract Poster Presenter: Oliver Sander, PhD (he/him/his) – Heinrich-Heine University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0167: Geographic and Demographic Patterns of Rheumatoid Arthritis in the United States: Insights from GBD 2021
    Location: Hall F1
    Abstract Poster Presenter: Punith Chirumamilla, MD (he/him/his) – Baptist Memorial Hospital North Mississippi
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0168: Risk of hospitalization in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasis: A matched cohort study
    Location: Hall F1
    Abstract Poster Presenter: QIANRU ZHANG, MD – Tsinghua University affiliated Beijing Tsinghua Changgung Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0169: The High Disease Burden of Connective Tissue Disorder-Interstitial Lung Disease in the USA Demonstrates an Unmet Need for Earlier Diagnosis and Treatment
    Location: Hall F1
    Abstract Poster Presenter: Sally Wetten, MA – GSK
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0170: Rheumatoid arthritis, serologic status and risk of heart failure: A national cohort study
    Location: Hall F1
    Abstract Poster Presenter: Seonyoung Kang, MD – Samsung Medical Center, Sungkyunkwan University School of Medicine
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0171: The Association Between Short-Term Trajectory Of Atmospheric Particulate Matter 10 (PM10) Concentration And Hyperuricemia
    Location: Hall F1
    Abstract Poster Presenter: Sunggun Lee, MD, PhD – Haeundae Paik Hospital, Inje University College of Medicine
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0172: Cancer Screening for Patients with Rheumatic Diseases: A Scoping Review
    Location: Hall F1
    Abstract Poster Presenter: Teresa Xiao, MD (she/her/hers) – University of Chicago
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0173: Association Between the Ratio of Non-high-density Lipoprotein Cholesterol to High-density Lipoprotein Cholesterol and All-cause Mortality Risk in Patients with Rheumatoid Arthritis: A Survival Analysis Based on NHANES Data
    Location: Hall F1
    Abstract Poster Presenter: Tingting Wang, n/a – Department of Rheumatology and Immunology, Dazhou Central Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0174: Genetic and Environmental Risk Factors and Incident Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Xuesen Zhao, MSc (he/him/his) – University of Miami
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0190: Health literacy and comorbidity burden: a cluster analysis in a national cohort of people with inflammatory arthritis
    Location: Hall F1
    Abstract Poster Presenter: Mrinalini Dey, MRCP, MA, MBBCH – Centre for Rheumatic Diseases, King's College London
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0197: Rheumatoid arthritis (RA) patients who screen positive for anxiety, depression, and/or fibromyalgia are more likely to report problems with sleeping, memory, and/or social activities than to have an abnormal rheumatoid factor or ACPA
    Location: Hall F1
    Abstract Poster Presenter: Theodore Pincus, MD, FACR, MACR – Rush University Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0358: Different Perspectives between Physicians and Patients on Treatment Priorities and Challenges in Still’s Disease
    Location: Hall F1
    Abstract Poster Presenter: Greta Rogani, MD – University Medical Center Utrecht
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0359: VA Is a Slow-moving Ship, but You Can Steer It”: Clinician Views on Navigating Shared Decision-making and Anticipated Use of an RA Decision Aid
    Location: Hall F1
    Abstract Poster Presenter: Jennifer L. Barton, MD – VA Portland Health Care System/OHSU
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0360: Assessing Content Validity of a New Questionnaire Evaluating Glucocorticoid Toxicity
    Location: Hall F1
    Abstract Poster Presenter: John Stone, MD, MPH – Massachusetts General Hospital , Harvard Medical School
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0361: Transition in Focus: Health Care Utilization and Disease Status in Youth with Connective Tissue Diseases— A Single-Center Experience in British Columbia, Canada
    Location: Hall F1
    Abstract Poster Presenter: Jude AlMasoud, MD (she/her/hers) – University of British Columbia
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0362: Drug Persistence of IL-17A Inhibitors Among Patients with PsA: Real-World Data from the CorEvitas PsA/SpA Registry
    Location: Hall F1
    Abstract Poster Presenter: Russel Burge, PhD – Eli Lilly and Company
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0363: Assessing Whole Health Needs in Systemic Lupus Erythematosus
    Location: Hall F1
    Abstract Poster Presenter: Amanda Eudy, PhD – Duke University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0364: Group-Based Medical Mistrust and Logistical Factors Influencing Rheumatology Clinical Trial Enrollment: A Single-Center Cross-Sectional Survey
    Location: Hall F1
    Abstract Poster Presenter: Andreina Martinez Paulino, MD (she/her/hers) – Rutgers Health/Jersey City Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0365: Clinical Characteristics and Psychosocial Outcomes of Patients with UCTD Compared to SLE
    Location: Hall F1
    Abstract Poster Presenter: Caroline Siegel, MD, MS – Hospital for Special Surgery
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0366: Dental Findings in Patients with Rheumatic Diseases and Its Association with Self-perceived Oral Health
    Location: Hall F1
    Abstract Poster Presenter: Fernanda Massiel Garcia Garcia, MD (she/her/hers) – Hospital Universitario "Dr. José Eleuterio González" UANL
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0367: Differences in Self-Reported Medication Nonadherence and its Drivers in Young Adults versus Older Adults with Systemic Lupus Erythematosus
    Location: Hall F1
    Abstract Poster Presenter: Hannah Concannon, BS – Duke University School of Medicine
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0368: Factors Associated with Patient Acceptability of Rheumatology Care Delivered by Telemedicine
    Location: Hall F1
    Abstract Poster Presenter: Hareem Farooq, MBBS (she/her/hers) – University of Alabama, Birmingham
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0369: Real-World Persistence of Janus Kinase Inhibitors in Biologic-Experienced Patients with Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Jeffrey Curtis, MD, MS, MPH – University of Alabama at Birmingham
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0370: Patient Preferences for Treatments of Rheumatoid Arthritis: A Discrete Choice Experiment Evaluating Preference for Advanced Drug Therapies and Neuroimmune Modulation Device
    Location: Hall F1
    Abstract Poster Presenter: Jeffrey Curtis, MD, MS, MPH – University of Alabama at Birmingham
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0371: Lifestyle Coaching in Psoriatic Arthritis: Pilot Findings from an Online eCoaching Program
    Location: Hall F1
    Abstract Poster Presenter: Judy Zhang, BS, BA – Cleveland Clinic Lerner College of Medicine
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0372: Development and Implementation of a Remote Educational Program to Optimize Safe Medication Use in Older Veterans with Rheumatic Diseases
    Location: Hall F1
    Abstract Poster Presenter: Maria Emilia Romero Noboa, MD – University of Alabama at Birmingham
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0373: Implementation of a Lupus Self-Management mHealth App: Using Incentives to Drive Engagement
    Location: Hall F1
    Abstract Poster Presenter: Melissa French, MS – Lupus Foundation of America
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0374: Assessing Attitudes and Barriers to Vaccination in Pediatric Rheumatic
    Location: Hall F1
    Abstract Poster Presenter: Merav Heshin Bekenstein, MD – Tel Aviv Medical Center Israel
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0375: Association of Glucocorticoid Toxicity Index Scores with Quality-of-life and Healthcare Resource Utilization at 6 Months in a Real-world Cohort of Individuals Receiving Glucocorticoids
    Location: Hall F1
    Abstract Poster Presenter: Naomi Patel, MD, MPH – Massachusetts General Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0376: An Internet-delivered, Arthritis-tailored Cognitive Behavioral Therapy for Insomnia Program for People with Co-morbid Sleep Disturbance: Comparing Baseline Characteristics of Cannabis Users and Non-users
    Location: Hall F1
    Abstract Poster Presenter: Nicole Andersen, BA,MA – McGill University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0377: New efforts to incorporate patient-reported outcomes into clinical trials for lupus therapeutics
    Location: Hall F1
    Abstract Poster Presenter: Patti Katz, PhD – UCSF
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0378: Identifying Patterns of Telemedicine Readiness and Digital Health Literacy in Rheumatoid Arthritis Patients: A Latent Class Analysis
    Location: Hall F1
    Abstract Poster Presenter: Preeti Dhanasekaran, PhD – National University of Singapore
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0379: Do Rheumatoid Arthritis Patients have Residual Fatigue Without Swollen Joints and Laboratory Inflammation? A Multicenter Study
    Location: Hall F1
    Abstract Poster Presenter: Rosa Morlà, MD,PhD,MSc (she/her/hers) – Hospital Clinic de Barcelona
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0380: Multidimensional Health Assessment Questionnaire (MDHAQ)/RAPID3, is an Useful Tool to Assess Comorbid and Residual Fatigue in Rheumatoid Arthritis Patients
    Location: Hall F1
    Abstract Poster Presenter: Rosa Morlà, MD,PhD,MSc (she/her/hers) – Hospital Clinic de Barcelona
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0381: Improving Participation in The Lupus Foundation of America’s Research Accelerated by You (RAY) Patient Registry By Understanding Patient Preference in Communication Strategies
    Location: Hall F1
    Abstract Poster Presenter: Safoah Agyemang, MS;BS;MSc – Lupus Foundation of America
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0382: Preventative Health Screening Practices Among 666 Women with Systemic Rheumatic Diseases from the Hospital for Special Surgery Rheumatology Women’s Reproductive Health and Wellness Cohort: A Cross-Sectional Analysis
    Location: Hall F1
    Abstract Poster Presenter: Sandhya Kannayiram, MD, MBBS (she/her/hers) – HOSPITAL FOR SPECIAL SURGERY/WEILL CORNELL
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0383: Hidden Risk in Low Frailty: Impact of Elixhauser Comorbidities on In-Hospital Mortality Among Osteoporosis Patients — A Nationwide Analysis
    Location: Hall F1
    Abstract Poster Presenter: Simran Bhimani, MD – The Wright Center for graduate medical education
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0384: Hip Fracture Hospitalization Trends in Osteoporotic Patients (2016–2022): National Data Insights
    Location: Hall F1
    Abstract Poster Presenter: Simran Bhimani, MD – The Wright Center for graduate medical education
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0385: Musculoskeletal Ultrasound Enhances Patient Insight and Clinical Decisions: A Multi-Center Study
    Location: Hall F1
    Abstract Poster Presenter: Simran Nimal, MBBS – Mayo Clinic
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0386: Introducing the Multidimensional Pain Inventory as a Comprehensive Tool or Assessing Pain in Patients With Axial Spondyloarthritis 
    Location: Hall F1
    Abstract Poster Presenter: Uta Kiltz, MD – Rheumazentrum Ruhrgebiet
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0357: Content validation of patient-reported outcome (PRO) measures for fatigue, physical function and disease activity in Polymyositis (PM)
    Location: Hall F1
    Abstract Poster Presenter: Esther Yi, MS, PharmD – Pfizer
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0175: Patient Satisfaction with a New Patient Video Triage Program
    Location: Hall F1
    Abstract Poster Presenter: Adam Dore, DO, RhMSUS – Allegheny Health Network
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0219: Increased Engagement With the RISE Registry Clinician Dashboard Is Associated With Improving Performance on Some but Not All Rheumatology Quality Measures
    Location: Hall F1
    Abstract Poster Presenter: Gabby Schmajuk, MD, MS – UCSF / SFVA
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0229: Leveraging the Electronic Medical Record to Improve the Rate of Discrete Data Collection in a Pediatric Rheumatology Clinic
    Location: Hall F1
    Abstract Poster Presenter: Lisa Buckley, MD – Vanderbilt University Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0180: Digital Transformation in IMID Care: Results from the Implementation of IMIDOC
    Location: Hall F1
    Abstract Poster Presenter: Chamaida Plasencia-Rodríguez, Sr, MD,PhD – Hospital Universitario La Paz
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0213: Development of a Predictive Tool for Obstetric Risk Stratification in Autoimmune Rheumatic Diseases: A Meta-Analysis-Based Model
    Location: Hall F1
    Abstract Poster Presenter: Braulio Avalos García, MS (he/him/his) – Universidad Autónoma de Nuevo Leon
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0223: Timely Dermatologic Diagnosis and Management Changes in Systemic Collagen Vascular Diseases: Experiences from the Rheumatology-Dermatology Combined Clinic
    Location: Hall F1
    Abstract Poster Presenter: Jeanie Lee, MD – Montefiore Einstein Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0177: Artificial Intelligence in Adult and Paediatric Rheumatology Practice and Research: Pilot Results from an International Survey
    Location: Hall F1
    Abstract Poster Presenter: Ana Isabel Rebollo-Giménez, MD – Department of Rheumatology, Gregorio Marañón University Hospital, Gregorio Marañón Health Research Institute
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0224: Improving Adherence to Pulmonary Hypertension Screening in Systemic Sclerosis Patients: Post-Intervention Analysis
    Location: Hall F1
    Abstract Poster Presenter: John Hickernell, MD – Loyola University Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0178: Prevalence and factors associated with virtual rheumatology care utilization in a national population of Veterans with RA
    Location: Hall F1
    Abstract Poster Presenter: Beth Wallace, MD, MS – Michigan Medicine, VA Ann Arbor Healthcare System
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0216: Evaluation of oral treatment adherence in Systemic Lupus Erythematosus patients: indentification of risks profiles
    Location: Hall F1
    Abstract Poster Presenter: Carmen Lasa Teja, n/a – Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain.
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0189: “try It, You’ll Love It”: Patterns of AI Scribes Use Among Rheumatologists
    Location: Hall F1
    Abstract Poster Presenter: Megan Creasman, MD – UC San Francisco
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0210: Improving Recombinant Zoster Vaccine Uptake in Younger Adults with Rheumatoid Arthritis through a Partnership with Specialty Pharmacy
    Location: Hall F1
    Abstract Poster Presenter: Akhil Sood, MD, MS – Washington University in St. Louis
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0218: Creating an EHR Lupus Outreach Workbench to Address Care Gaps
    Location: Hall F1
    Abstract Poster Presenter: Christie Bartels, MD, MS – University of Wisconsin School of Medicine and Public Health
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0232: Hydroxychloroquine Blood Testing in Lupus: The Michigan Medicine Experience
    Location: Hall F1
    Abstract Poster Presenter: Zeinab Saleh, MD – University of Michigan
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0188: Investigating Canadians’ information needs related to lupus: A Google Trends analysis of online search query data
    Location: Hall F1
    Abstract Poster Presenter: May Choi, MD, FRCPC, MPH – University of Calgary
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0214: Systematic Comorbidity Screening in Inflammatory Arthritis: The Experience of a Tertiary-Care Centre
    Location: Hall F1
    Abstract Poster Presenter: Camille Bourgeois, MD – Hospital general universitario Gregorio Marañón
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0191: Advanced Therapy Use in RA Patients with Moderate Disease Activity in a Large NHS Foundation Trust in South London, UK
    Location: Hall F1
    Abstract Poster Presenter: Mrinalini Dey, MRCP, MA, MBBCH – Centre for Rheumatic Diseases, King's College London
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0193: Evaluation of electronic health record and efficiency tool utilization by pediatric subspecialists
    Location: Hall F1
    Abstract Poster Presenter: Samantha Coss, MD, PhD (she/her/hers) – Nationwide Children's Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0215: Impact of Global Review on Comorbidity Management in Inflammatory Arthritis Patients
    Location: Hall F1
    Abstract Poster Presenter: Camille Bourgeois, MD – Hospital general universitario Gregorio Marañón
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0187: Message Testing in Online Recruitment Advertisements for a National Rheumatoid and Psoriatic Arthritis Study
    Location: Hall F1
    Abstract Poster Presenter: Matthew Kearney, MPH, PhD – University of Pennsylvania
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0225: Positive anxiety, depression and/or fibromyalgia screening on validated MDHAQ indices is seen in 30-50% of routine care patients with all rheumatic diagnoses
    Location: Hall F1
    Abstract Poster Presenter: Juan Schmukler, MD – Rush University Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0182: A Joint Effort: Implementing Depression Screening in a Safety-net Rheumatology Clinic
    Location: Hall F1
    Abstract Poster Presenter: Clare Grossman, BA – UCSF School of Medicine
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0195: Utility of Repeat ANA Testing
    Location: Hall F1
    Abstract Poster Presenter: Sila Mateo Faxas, MD (she/her/hers) – Good Samaritan Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0227: Malignancy Screening of Dermatomyositis Patients in the Penn State Registry of Inflammatory Myopathies (PRIMO)
    Location: Hall F1
    Abstract Poster Presenter: Katrina Gonzales, BA (she/her/hers) – Penn State College of Medicine
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0185: Promoting Health Services Research Rigor and Reproducibility using CodeMapper: A novel tool for harmonization, collaboration, and precision
    Location: Hall F1
    Abstract Poster Presenter: Emily Holladay, MPH – University of Alabama at Birmingham
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0226: Integration of the 5Ms of Geriatrics in a Novel Geri-Rheumatology Clinic
    Location: Hall F1
    Abstract Poster Presenter: Justin Levinson, MD, MBA – University of Wisconsin- Madison
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0192: Digital Empowerment on Hold: Adoption Gaps in Prescribable Digital Health Applications – A National Cross-Sectional Study from Germany
    Location: Hall F1
    Abstract Poster Presenter: Phillip Kremer, MD – University Hospital Hamburg Eppendorf
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0211: Initial Results From a Single-Center Quality Improvement Initiative Using the Shingrix Rheumatology Immunization Dashboard Within the Veterans Health Administration
    Location: Hall F1
    Abstract Poster Presenter: Alexandra Do, MD (she/her/hers) – Oregon Health and Science University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0196: Increasing Timely Rheumatology Evaluation for High Risk Lupus Patients
    Location: Hall F1
    Abstract Poster Presenter: Steven Taylor, MD, RhMSUS – University of Colorado
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0194: Evaluation of a Home-based Therapeutics Service: Feasibility, Patient and Caregiver Experience, and Cost
    Location: Hall F1
    Abstract Poster Presenter: Siaw Ing Yeo, MBBS, MSc, FRCP, MRCP – Singapore General Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0176: Development and Validation of an Accurate Patient Reported Outcome Measure-based Disease Activity Score to Enable Remote Monitoring in RA
    Location: Hall F1
    Abstract Poster Presenter: Agnes Looijen, MD – Erasmus MC
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0221: A Multimodal Intervention Improves the Quantity and Quality of Disease Activity Measures Collection in a Multi-centered National Rheumatoid Arthritis Network
    Location: Hall F1
    Abstract Poster Presenter: Grant Cannon, MD – University of Utah and Salt Lake City VA
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0186: Validation of Asynchronous Telehealth Visit for Adults and Children with Inflammatory Arthritis and Feasibility of Applying Thermal Imaging during Visits
    Location: Hall F1
    Abstract Poster Presenter: Jenna Thomason, MD, MPH – University of Washington
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0222: Evaluating the Barriers and Facilitators for Collecting and Documenting Rheumatoid Arthritis Disease Activity Measures Using a Rheumatology Provider Survey
    Location: Hall F1
    Abstract Poster Presenter: Isaac Smith, MD, MSc – Duke University Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0179: Digital Divide in Rheumatology: Patterns of Technology and AI Adoption Across Generations of Specialists
    Location: Hall F1
    Abstract Poster Presenter: Carla F Dionello, PhD (she/her/hers) – UFRJ
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0220: National Implementation of a Medication Safety Dashboard to Improve HLA-B*58:01 Testing Among Allopurinol Users in the Veterans Health Administration
    Location: Hall F1
    Abstract Poster Presenter: Gabby Schmajuk, MD, MS – UCSF / SFVA
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0198: Variation in RA disease activity measure assessment and treatment change documentation in virtual vs in-office rheumatology visits
    Location: Hall F1
    Abstract Poster Presenter: Yasmin Khader, MD, MPH – University of Michigan
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0231: A Quality Improvement Project to Explore the Implications of the 2020 ACR Gout Guideline Recommendations for HLA-B5801 Testing
    Location: Hall F1
    Abstract Poster Presenter: Sarah Anstett, MD (she/her/hers) – Hospital at University of Pennsylvania
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0181: Launch of the National Tele-Rheumatology Program (NTRP) to Expand Rheumatology Care to Rural Veterans
    Location: Hall F1
    Abstract Poster Presenter: Cherish Wilson, BA – UCSF / SFVA
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0217: Development of the American College of Rheumatology Implementation Guide for Integrating Patient Reported Systemic Lupus Erythematosus Quality Measures
    Location: Hall F1
    Abstract Poster Presenter: Catherine Nasrallah, MPH, BS (she/her/hers) – University of California San Francisco
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0183: Optimizing the Clinical Application of Rheumatology Guidelines Using Large Language Models: A Retrieval-Augmented Generation Framework Integrating EULAR and ACR Recommendations
    Location: Hall F1
    Abstract Poster Presenter: Dalifer Freites Nuñez, MD, PhD – Hospital Clínico San Carlos. Madrid. Spain.
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0212: Biomarker-Guided Therapeutic Calculator for Personalized Management in Pregnant Patients with Autoimmune Rheumatic Diseases
    Location: Hall F1
    Abstract Poster Presenter: Andres Manuel Ortiz-Rios, Sr, BS (he/him/his) – Facultad de Medicina, Universidad Autonoma de Nuevo Leon
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0230: An Epic Journey – Therapeutic Drug Monitoring at an Academic Center
    Location: Hall F1
    Abstract Poster Presenter: Puja Khanna, MD, MPH – University of Michigan
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0184: Neurocognitive Complications of Lupus: A Multidisciplinary Program Model for Advanced Diagnostics, Management, and Clinical Research
    Location: Hall F1
    Abstract Poster Presenter: Douglas Wilcox, MD, PhD – Brigham and Women's Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0228: Bridging the Gap: Leveraging Econsultation to Improve Access to Quality Gout Care
    Location: Hall F1
    Abstract Poster Presenter: Laura Nichols, MD, FACP – University of Colorado
  • Sunday, Oct 26th
    1:00 PM - 2:30 PM Central Time
    26S32: Abstracts: Patient Outcomes, Preferences, & Attitudes
    Location: S102
    Abstract Moderator: Martin Bergman, MD, FACR, MACR – self
    Abstract Moderator: Betty Hsiao, MD – Yale-New Haven Medical Center
     CE: 0.00
  • Sunday, Oct 26th
    1:00 PM - 1:15 PM Central Time
    0789: Short Form 36 (SF-36) Health Survey Questionnaire in Health-Related Quality of Life Assessment in Patients with Inflammatory Myopathies
    Location: S102
    Presenting Author: Almurtada Razok, MD, MRCP (he/him/his) – Loyola Medicine MacNeal Hospital
  • Sunday, Oct 26th
    1:15 PM - 1:30 PM Central Time
    0790: Diabetes Risk in Psoriasis Patients Treated with Biologic Disease-Modifying Antirheumatic Drugs: Target Trial Emulation Using Nationwide Data
    Location: S102
    Presenting Author: Arjun Mahajan, MS – Harvard Medical School
  • Sunday, Oct 26th
    1:30 PM - 1:45 PM Central Time
    0791: Disagreements in Disease Activity Measures in an Evaluation of SLE Outcome Measures in Telemedicine
    Location: S102
    Presenting Author: Leila Khalili, MSN, FNP, APRN – Columbia University Medical Center
  • Sunday, Oct 26th
    1:45 PM - 2:00 PM Central Time
    0792: Real-World Assessment of Glucocorticoid-Induced Skin Toxicity in Individuals with Rheumatic Diseases
    Location: S102
    Presenting Author: Tania Chiha, MD – Mount Auburn Hospital
  • Sunday, Oct 26th
    2:00 PM - 2:15 PM Central Time
    0793: The weight of the past: how trauma and resilience shape medication adherence in SLE
    Location: S102
    Presenting Author: Kai Sun, MD, MS, RhMSUS – Duke University
  • Sunday, Oct 26th
    2:15 PM - 2:30 PM Central Time
    0794: Using Artificial Intelligence to Analyze Multilingual Qualitative Data in Lupus Pregnancy Research: A Proof of Concept with Large Language Models
    Location: S102
    Presenting Author: Bella Mehta, MD, MS, MBBS – Hospital for Special Surgery, Weill Cornell Medicine
  • Sunday, Oct 26th
    2:30 PM - 3:30 PM Central Time
    26S47: MIPS and MVPs: What Clinicians Need to Know for 2026 and Beyond
    Location: W475A-B
    Moderator: Thomas Tack, BS – American College of Rheumatology
    Moderator: Beth Radtke, MS – ACR
    Session Coordinator: Deanna Jannat-Khah, MPH, DrPH – Hospital For Special Surgery
     CE: 1.00
  • Sunday, Oct 26th
    2:30 PM - 2:50 PM Central Time
    Introduction and Overview of Alternative Payment Model (APM), Merit-based Incentive Payment System (MIPS), and MIPS Value Pathways (MVPs)
    Location: W475A-B
    Speaker: Puneet Bajaj, MD, MPH – UT Southwestern Medical Center
  • Sunday, Oct 26th
    2:50 PM - 3:10 PM Central Time
    Using RISE to Easily and Effectively Report MIPS and MVPs
    Location: W475A-B
    Speaker: Nandini Setia, MD – Articularis Healthcare Group
  • Sunday, Oct 26th
    3:10 PM - 3:30 PM Central Time
    Panel Discussion
    Location: W475A-B
    Panelist: Puneet Bajaj, MD, MPH – UT Southwestern Medical Center
    Panelist: Nandini Setia, MD – Articularis Healthcare Group
  • Sunday, Oct 26th
    4:00 PM - 5:00 PM Central Time
    26S61: Designing Stronger Clinical Trials: Choosing the Best Comparator for Impactful Results
    Location: W184B-C
    Moderator: Daniel White, PT, ScD – University of Delaware
    Moderator: Joshua J. Stefanik, PhD, PT – Northeastern University
    Session Coordinator: Joshua J. Stefanik, PhD, PT – Northeastern University
     CE: 1.00
  • Sunday, Oct 26th
    4:00 PM - 5:00 PM Central Time
    26S65: Championing Change for Children and Young Adults with Rheumatic Diseases: Legislative and Policy Update
    Location: W471B
    Moderator: Bryce Binstadt, MD,PhD – University of Minnesota
    Moderator: Ekemini Ogbu, MD, MSc – Cincinnati Children's Hospital Medical Center
    Session Coordinator: Susan Shenoi, MS, MBBS, RhMSUS – Seattle Children's Hospital and Research Center
    Session Coordinator: Ekemini Ogbu, MD, MSc – Cincinnati Children's Hospital Medical Center
     CE: 1.00
  • Sunday, Oct 26th
    4:00 PM - 4:30 PM Central Time
    Choosing a Comparator
    Location: W184B-C
    Speaker: Rana Hinman, PhD – University of Melbourne
  • Sunday, Oct 26th
    4:00 PM - 4:30 PM Central Time
    The Impact of Policy on Healthcare: Lessons from a Parent
    Location: W471B
    Speaker: Shiloh Kantz, -None- – Oklahoma Policy Institute
  • Sunday, Oct 26th
    4:30 PM - 5:00 PM Central Time
    Advocating for Children and Young Adults with Chronic Diseases
    Location: W471B
    Speaker: Madelaine Feldman, MD – THE RHEUMATOLOGY GROUP
  • Sunday, Oct 26th
    4:30 PM - 5:00 PM Central Time
    Statistical Considerations
    Location: W184B-C
    Speaker: Elena Losina, PhD – BWH
  • Monday, Oct 27th
    10:00 AM - 11:00 AM Central Time
    27M26: Rx for Better Outcomes: In-Office Infusions and Dispensing Using an Integrated Clinical Team
    Location: W475A-B
    Moderator: Priya Reddy, MD – AARA - Southwest Florida Rheumatology
    Session Coordinator: Priya Reddy, MD – AARA - Southwest Florida Rheumatology
    Moderator: Kaleb Michaud, PhD – University of Nebraska Medical Center
     CE: 1.00
  • Monday, Oct 27th
    10:00 AM - 10:30 AM Central Time
    How I Have Integrated a Clinical Pharmacist to Optimize Infusions and Dispening in My Office
    Location: W475A-B
    Speaker: Waleed Bolad, MD – Self Employed
  • Monday, Oct 27th
    10:30 AM - 11:00 AM Central Time
    My Role as a Clinical Pharmacist in the Rheumatology Clinic
    Location: W475A-B
    Speaker: Katharine McCarthy, PharmD – University of Rochester Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    ARP Posters I: ARP Epidemiology & Public Health
    Location: Hall F1
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    Epidemiology & Public Health Poster II
    Location: Hall F1
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    Health Services Research Poster II
    Location: Hall F1
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    Patient Outcomes, Preferences, & Attitudes Poster II
    Location: Hall F1
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1007: Accelerometry-derived Activity and Sleep Patterns in the NIH All of Us Cohort: Insights and Predictive Potential for Inflammatory Arthritis
    Location: Hall F1
    Abstract Poster Presenter: adeep Kulkarni, MS (he/him/his) – New York University Grossman School of Medicine
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1008: Nationwide Historical Cohort Study on the Primary Prophylactic Effects of Colchicine in Cardiovascular Events
    Location: Hall F1
    Abstract Poster Presenter: Ahmet Gül, MD – Istanbul University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1009: Pregnancy Outcomes and Comorbidities Among Individuals with Systemic Lupus Erythematosus: A Nationwide Study Using Publicly Funded Health Insurance Claims Data
    Location: Hall F1
    Abstract Poster Presenter: Amadeia Rector, MPH – Stanford University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1010: Confounding by Indication in Observational Studies Investigating Glucocorticoid-Associated Adverse Events in Patients with Rheumatoid Arthritis: A Systematic Literature Review
    Location: Hall F1
    Abstract Poster Presenter: Andriko Palmowski, MD – Charité - Universitätsmedizin Berlin
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1011: Model-based Evaluation of the Potential Public Health Impact of Expanding Medicare Coverage for Weight Loss Medications for Beneficiaries with Knee Osteoarthritis and Obesity in the US.
    Location: Hall F1
    Abstract Poster Presenter: Ethan Eickmann, BA – Brigham and Women's Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1012: Racial and Gender Disparities in Gout Clinical Trials
    Location: Hall F1
    Abstract Poster Presenter: Fizza Zulfiqar, MD (she/her/hers) – University of Minnesota
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1013: All Roads Lead to Rheum? Modeling Scenarios of New Patients-to-pediatric Rheumatologist Ratios in Different US States
    Location: Hall F1
    Abstract Poster Presenter: Gabriela Accetta Rojas, MD, MSCE (she/her/hers) – Nemours Children's Hospital of Delaware
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1014: Factors Associated with Fibromyalgia Diagnosis amongst People Meeting Criteria: Results from UK Biobank
    Location: Hall F1
    Abstract Poster Presenter: Gary Macfarlane, MD, PhD, BSc, MBChB, DSc – University of Aberdeen
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1015: Refining Administrative Algorithms For Accurate Identification of Patients with Systemic Sclerosis In Trinetx Research Network
    Location: Hall F1
    Abstract Poster Presenter: Gulsen Ozen, MD – University of Iowa Carver College of Medicine
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1016: Association Between Inflammatory Biomarkers and Predicted Heart Failure Risk in Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Ilana Usiskin, MD – Brigham and Women's Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1017: Effectiveness of Recombinant Zoster Vaccine in Reducing Herpes Zoster Incidence and All-Cause Mortality Among Rheumatoid Arthritis Patients: A Retrospective Cohort Study of 21,046 Individuals from TriNetX U.S. Collaborative Network
    Location: Hall F1
    Abstract Poster Presenter: James Cheng-Chung Wei, ORCID: http://orcid.org/0000-0002-1235-0679 – Chung Shan Medical University Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1018: Factors Associated with Mortality in Systemic Lupus Erythematosus under a Universal Healthcare System: Results from the CAPTURED Study, a Population-Based Cohort in Catalonia, Spain
    Location: Hall F1
    Abstract Poster Presenter: Jose A. Gomez-Puerta, MD, PhD, MPH – Hospital Clínic
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1019: Associations Between Mental Health Diagnoses and Acute Care Use Among Individuals with Systemic Lupus Erythematosus in the All of Us Research Program
    Location: Hall F1
    Abstract Poster Presenter: Karen Costenbader, MD, MPH – Brigham and Women's Hospital/ Harvard Medical School
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1020: Cohort Study of European Ancestry, Geographic Region, Ambient Ultraviolet Irradiance and the Risk of Developing Polymyalgia Rheumatica among Women
    Location: Hall F1
    Abstract Poster Presenter: Karen Costenbader, MD, MPH – Brigham and Women's Hospital/ Harvard Medical School
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1021: Recent Trends in Cannabis Use Among Individuals with Rheumatic Diseases
    Location: Hall F1
    Abstract Poster Presenter: Kristin Wipfler, PhD (she/her/hers) – FORWARD, The National Databank for Rheumatic Diseases
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1022: Abuse in Rheumatic Diseases: Associations with Depression, Disability, and Psychosocial Risk Factors
    Location: Hall F1
    Abstract Poster Presenter: Margarita Isabel Alarcón Jarquin, MD (she/her/hers) – Hospital universitario Dr. José Eleuterio González
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1023: Comparative Analysis of Oral Health and Dental Care in Patients With Immune-Mediated and Non-Immune-Mediated Rheumatic Diseases
    Location: Hall F1
    Abstract Poster Presenter: Margarita Isabel Alarcón Jarquin, MD (she/her/hers) – Hospital universitario Dr. José Eleuterio González
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1024: Mortality In Progressive Pulmonary Fibrosis Associated to Autoimmune Diseases: NEREA Registry
    Location: Hall F1
    Abstract Poster Presenter: Marta Ruiz-Valdepeñas Almansa, MD – Hospital Clínico San Carlos
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1025: Association Between Rural-urban Clinics and the Management of Adult Rheumatoid Arthritis in the United States
    Location: Hall F1
    Abstract Poster Presenter: Megan Lorenz, BA – University of North Dakota School of Medicine and Health Sciences
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1026: Seasonal Variation in Public Interest in Gout Made More Crystal-Clear: A Longitudinal Infodemiology Study Using Google Trends.
    Location: Hall F1
    Abstract Poster Presenter: Naomi Schlesinger, MD – University of Utah
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1027: GLP-1 Receptor Agonists to Facilitate Weight Loss and Improve Disease Activity, Pain and Function in Patients With Rheumatic and Musculoskeletal Disease: Real-World Evidence From the Rheumatology Informatics System for Effectiveness (RISE) Registry
    Location: Hall F1
    Abstract Poster Presenter: Nicholas McCormick, BS – Auburn University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1028: Enhanced Assessment of Psoriatic Arthritis Disease Progression Using cDAPSA plus the Contrast of Patient Reported Pain and Global Assessment versus Joint Counts
    Location: Hall F1
    Abstract Poster Presenter: Ning Meng, MBBS, MHS – Johns Hopkins University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1029: Cervical cancer screening rates in Korean women of childbearing age with systemic lupus erythematosus
    Location: Hall F1
    Abstract Poster Presenter: PIL GYU PARK, MD (he/him/his) – National Health Insurance Service Ilsan Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1030: Predictors of Incident Atrial Fibrillation in Rheumatoid Arthritis Patients: A Population Based Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Sarah Pimple, MD (she/her/hers) – Mayo Clinic
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1031: Trends and Gender Disparities in Rheumatoid Arthritis Burden in the United States: A Population-Based Time-Trend Analysis Using the Global Burden of Disease Database, 1990–2021
    Location: Hall F1
    Abstract Poster Presenter: Satani Sharkas, MD – Boston Medical Center - Brighton
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1032: Exploring the role of the gut microbiome in gout: Prospective analysis of dietary fiber intake and the risk of gout
    Location: Hall F1
    Abstract Poster Presenter: Sharan Rai, PhD – Massachusetts General Hospital, Harvard Medical School
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1033: Rethinking ANA in Rheumatoid Arthritis: ICAP Pattern Insights from a Large-Scale Taiwanese Cohort
    Location: Hall F1
    Abstract Poster Presenter: Tien-Ming Chan, MD – Chang Gung Memorial Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1034: Healthy Dietary Patterns and Risk of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
    Location: Hall F1
    Abstract Poster Presenter: Vanessa Kronzer, MD, MSc – Mayo Clinic
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1035: Demographic and Clinical Correlates of 30 day Re-admission or Death During Admission in Patients With Rheumatologic Conditions : A Retrospective Cohort Analysis in a Single Academic Center
    Location: Hall F1
    Abstract Poster Presenter: Waleed Ali, MD (he/him/his) – Washington University/Barnes Jewish Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1036: Factors Associated With Long-term Remission After Drug Discontinuation In IgG4-related Disease: A 3-Year Rule
    Location: Hall F1
    Abstract Poster Presenter: Yifei Wang, BS (she/her/hers) – Peking Union Medical College
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1037: Risk Factor Identification and Dynamic Individualized Prediction of Muscle Involvement in Systemic Sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Zixing Liu, MS – Johns Hopkins University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1248: Patient and Clinician Perception and Use of Complementary and Alternative (CAM) Medicine for Rheumatic Disease
    Location: Hall F1
    Abstract Poster Presenter: Ailia Ali, MD – Franciscan Health
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1249: Association Between Positive Emotions and Physical Function in Early Rheumatoid Arthritis Patients
    Location: Hall F1
    Abstract Poster Presenter: Burcu Aydemir, MS, PhD – Northwestern University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1250: Patient Perceptions of the National Tele-Rheumatology Program: A Mixed Methods Study
    Location: Hall F1
    Abstract Poster Presenter: Catherine Nasrallah, MPH, BS (she/her/hers) – University of California San Francisco
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1251: Steroids and Me (Sam): engaging and educating steroid-treated patients via patient advocacy partnerships and internet search channels.
    Location: Hall F1
    Abstract Poster Presenter: Martha Stone, -None-, BA – Steritas, LLC
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1252: Can LLMs Categorize Patient Priorities Like Humans? Comparing AI and Human Coders in Arthritis Nominal Group Discussions
    Location: Hall F1
    Abstract Poster Presenter: Melissa Mannion, MD – University of Alabama at Birmingham
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1253: Patient Reported Outcome Measures: Assessing Resident Physician Acceptance of the Routine Assessment of Patient Index Data 3 Survey and its Impact on Physician-Patient Relationship
    Location: Hall F1
    Abstract Poster Presenter: Nisha Sapkota, MD – One Brooklyn Health- Interfaith Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1254: Symptom Burden and Treatment Experience in Fibromyalgia: Results From a National Patient Survey
    Location: Hall F1
    Abstract Poster Presenter: Parul Houston, PhD – Axsome Therapeutics, Inc
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1255: Lung Transplantation Outcomes for Pulmonary Sarcoidosis Compared to Idiopathic Pulmonary Fibrosis: A Single Institution Multisite Experience
    Location: Hall F1
    Abstract Poster Presenter: Reena Yaman, MD, MS, BSc (she/her/hers) – Mayo Clinic Florida
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1256: Quantitative Analysis of a Pilot Study: Integrating Behavioral Health Services for Patients with Rheumatic Diseases
    Location: Hall F1
    Abstract Poster Presenter: Shannon Teaw, MD – University of Washington
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1257: Integrated Behavioral Health Services for Patients with Rheumatic Diseases: Qualitative Analysis of a Pilot Study
    Location: Hall F1
    Abstract Poster Presenter: Shannon Teaw, MD – University of Washington
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1258: Upadacitinib in the treatment of Rheumatoid Arthritis - Interstitial Lung Disease. National multicenter study of 25 patients in clinical practice.
    Location: Hall F1
    Abstract Poster Presenter: Ana Serrano-Combarro, MD – Division of Rheumatology, Hospital Universitario Marques de Valdecilla, IDIVAL, Inmunopathology group, Santander
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1259: Patient and Caregiver Perspectives on the Burden of Disease in Uncontrolled Gout: A Cross-Sectional Survey Study
    Location: Hall F1
    Abstract Poster Presenter: Angelo Gaffo, MD, FACP – University of Alabama at Birmingham
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1260: Increasing Zoster Vaccination Rates in Immunosuppressed Veterans at the North Texas VA Medical Center Rheumatology Clinic
    Location: Hall F1
    Abstract Poster Presenter: Benjamin Gardner, MD – Dallas Rheumatology
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1261: Use of telemedicine to address ‘off target’ symptoms in psoriatic arthritis (PsA): implementation of PsOWell™ in PsA
    Location: Hall F1
    Abstract Poster Presenter: Carter Pason, MS – University of Pennsylvania
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1262: Perspectives of Lupus Patients on Quality of Life Measures: A Qualitative Study
    Location: Hall F1
    Abstract Poster Presenter: Cristina Arriens, MD, MS – Oklahoma Medical Research Foundation
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1263: Health Literacy diversity among rheumatology patients: insights from a tertiary rheumatology centre
    Location: Hall F1
    Abstract Poster Presenter: Cristina Calomarde-Gomez, MD – Hospital Universitari Germans Trias i Pujol
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1264: Breaking the Veil: Preliminary Findings for a Qualitative Analysis of Rheumatoid Arthritis Patient Perspectives on Physical Activity and Mental Healt
    Location: Hall F1
    Abstract Poster Presenter: Daniel Garcia, BS (he/him/his) – Weill Cornell Medicine
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1265: Patient Portal Awareness and Utilization Across Diverse Rheumatology Populations
    Location: Hall F1
    Abstract Poster Presenter: Emily Gutowski, MD – NYU
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1266: Shared Decision Making in Rheumatoid Arthritis: Is RA disease activity associated with patient reported measures of shared decision making pre-SDM intervention?
    Location: Hall F1
    Abstract Poster Presenter: Jennifer L. Barton, MD – VA Portland Health Care System/OHSU
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1267: Patient Reported Outcomes Predict Subsequent Treatment Intensification Among Rheumatoid Arthritis Patients: Longitudinal PRO Measurement Using a Mobile Health App
    Location: Hall F1
    Abstract Poster Presenter: Leah Santacroce, MS – Brigham and Women's Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1268: Development of the LupusCoach Chatbot: Results of a Focus Group
    Location: Hall F1
    Abstract Poster Presenter: Leila Khalili, MSN, FNP, APRN – Columbia University Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1269: Dress for success: Influence of Rheumatologist Demographics and Attire on Patients with Chronic Inflammatory Arthritis Perceptions
    Location: Hall F1
    Abstract Poster Presenter: Leticia Leon, PhD, MSc (she/her/hers) – Hospital Clinico San Carlos
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1270: Increasing Participation in the FT819 Cell Therapy Trial Amongst People Living with Lupus: A Focus Group Study
    Location: Hall F1
    Abstract Poster Presenter: Michael Fisher, PhD – Lupus Foundation of America
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1271: Overcoming Obstacles to Care: Survey of Adult Patients with Idiopathic Inflammatory Myopathies (IIM)
    Location: Hall F1
    Abstract Poster Presenter: Saloni Patolia, MD (she/her/hers) – University of North Carolina Chapel Hill
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1633: Social Determinants of Health and Adverse Perinatal Outcomes in Women with Rheumatic Diseases
    Location: Hall F1
    Abstract Poster Presenter: Braulio Avalos García, MS (he/him/his) – Universidad Autónoma de Nuevo Leon
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1634: Association of Systemic Lupus Erythematosus with Incident Heart Failure Requiring Hospitalization
    Location: Hall F1
    Abstract Poster Presenter: Chun-Yu Lin, MD – Kaohsiung Veterans General Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1635: Association Between Treatment Adherence and Frailty in Patients with Rheumatic Diseases
    Location: Hall F1
    Abstract Poster Presenter: Daniela L. Guillen-Tejada, MD – Universidad de las Américas Puebla
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1636: The Impact of Arthritis on Self-Management Activities of West Virginia Adults with Type 2 Diabetes During the COVID-19 Pandemic
    Location: Hall F1
    Abstract Poster Presenter: Dina Maruca, PhD, PT – West Virginia University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1637: Sleep Quality as a Modifier of the Relationship Between Physical Activity and Functional Limitation in Adults with or at High Risk of Knee Osteoarthritis
    Location: Hall F1
    Abstract Poster Presenter: Jason Jakiela, PhD, MS – Winston-Salem State University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1638: Comparison and Assessment of the All of Us Dataset for Epidemiologic Studies of Systemic Lupus Erythematosus (SLE) Among African American Women
    Location: Hall F1
    Abstract Poster Presenter: Katherine Singleton, BS (she/her/hers) – Emory University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1639: Concordance of Self-Reported Physical Functioning and Physical Performance in SLE: A Cross-Cohort Analysis
    Location: Hall F1
    Abstract Poster Presenter: Laura Plantinga, PhD, MSc – University of California, San Francisco
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1640: Physical Function and Performance in SLE: A Comparison of Two Population-Based Cohorts
    Location: Hall F1
    Abstract Poster Presenter: Laura Plantinga, PhD, MSc – University of California, San Francisco
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1641: Association of Area Socioeconomic Deprivation with Community Mobility in a Diverse Cohort of Individuals with SLE
    Location: Hall F1
    Abstract Poster Presenter: Laura Plantinga, PhD, MSc – University of California, San Francisco
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1642: The Impact of Secukinumab on Bone Density in Patients with Ankylosing Spondylitis: A 1-Year Retrospective Study
    Location: Hall F1
    Abstract Poster Presenter: Lemei An, MD – Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1643: Optimizing Analyses of Chair Stand Test Outcome Data in the Multicenter Osteoarthritis Study: Exploration of Approaches to Handling Missing and/or Skewed Data with Performance-based Function Measures
    Location: Hall F1
    Abstract Poster Presenter: Michael LaValley, PhD – Boston University School of Public Health
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1644: Longitudinal Trajectory Models to Assess Pain and Risk of Difficult-to-Treat Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Misti Paudel, PhD, MPH – Brigham and Women's Hospital, Division of Rheumatology, Inflammation, and Immunity
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1645: A Sex-modified Association Between Perfluoroalkyl and Polyfluoroalkyl Substances (PFAS) Blood Concentration and Prevalent Arthritis Among Young and Middle-aged US Adults
    Location: Hall F1
    Abstract Poster Presenter: Queeneth Edwards, MD, MPH – Georgia Southern University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1646: The Obesity Paradox in Rheumatoid Arthritis: A Propensity-Matched Analysis of Mortality and Cardiovascular Outcomes
    Location: Hall F1
    Abstract Poster Presenter: Queeneth Edwards, MD, MPH – Georgia Southern University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1647: Clinical Phenotypes of Participants with Radiographic Osteoarthritis Attaining Patient Acceptable Symptom State in the Multicenter Osteoarthritis Study
    Location: Hall F1
    Abstract Poster Presenter: Sarah Tilley, MS (she/her/hers) – Boston University School of Medicine
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1648: Predicting Worse Disease Activity, QOL, and Progression to Advanced Therapies at 12 and 24 months in Early RA: Results from the Canadian Early Arthritis Cohort (CATCH)
    Location: Hall F1
    Abstract Poster Presenter: Susan Bartlett, PhD – McGill University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1649: Does Physical Activity Differ Among those with Autoimmune vs Non-Autoimmune Rheumatic Diseases?
    Location: Hall F1
    Abstract Poster Presenter: Sydney Liles, MS, PT, DPT (she/her/hers) – University of Delaware
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1039: CAR-T Therapy in Rheumatoid Arthritis: A Health Systems Analysis of Cost and Global Equity
    Location: Hall F1
    Abstract Poster Presenter: Asrith Reddy Gandu, MBBS – Davao Medical School Foundation
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1049: Provider Characteristics and Beliefs and Patient Factors Associated with Long-term Glucocorticoid Use in Patients with Rheumatoid Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Michael George, MD, MSc – University of Pennsylvania
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1038: Real-World Immunosuppressant Treatment Patterns in Lupus Nephritis: A Retrospective Claims Database Analysis in the United States
    Location: Hall F1
    Abstract Poster Presenter: Anisha Patel, PhD – Genentech Inc.
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1050: Bridging the Gap: A Mixed-Methods Study to Enhance Integration of HCQ-SAFE, A Shared Decision-Making Tool for Hydroxychloroquine Use, in Routine Lupus Care
    Location: Hall F1
    Abstract Poster Presenter: Shivani Garg, MD, PhD – University of Madison, School of Medicine and Public Health
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1051: Mitigating Hydroxychloroquine (HCQ) Nonadherence by Clarifying Misbeliefs Using a Shared Decision-Making Tool (HCQ-SAFE©) Across Two Different Rheumatology Centers
    Location: Hall F1
    Abstract Poster Presenter: Shivani Garg, MD, PhD – University of Madison, School of Medicine and Public Health
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1052: “prednisone… a Necessary Evil…” Developing an Evidence-based Benefits vs. Harms Shared Decision-making Tool (PRED-SAFE) to Support Decisions Around Chronic Prednisone Use
    Location: Hall F1
    Abstract Poster Presenter: Shivani Garg, MD, PhD – University of Madison, School of Medicine and Public Health
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1054: Comedication Patterns of Romosozumab Early Adopters Among Medicare Enrollees: An Unsupervised Clustering Approach
    Location: Hall F1
    Abstract Poster Presenter: Ye Liu, MD, MPH, DrPH – University of Alabama at Birmingham
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1045: Bayesian Analysis of Factors Associated with Romosozumab Adherence Among Early Adopters in Medicare Beneficiaries
    Location: Hall F1
    Abstract Poster Presenter: Hongke Wu, MD, MS, MPH – University of Alabama at Birmingham
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1046: Cannabis Knowledge, Attitudes, and Practices Among Rheumatology Providers: Implications for Clinical Care and Education
    Location: Hall F1
    Abstract Poster Presenter: Joanna Zeiger, PhD, MS – Canna Research Foundation
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1044: Analysis of Medicare and Medicaid Utilization and Expenditure of Newly Approved Biologics for Systemic Lupus Erythematosus Patients in the United States
    Location: Hall F1
    Abstract Poster Presenter: Gunjan Rana, MD (she/her/hers) – Saint Vincent Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1053: Trends in Cost and Utilization of Biologic Medications for Rheumatologic Conditions: A Medicare Claims Study (2013–2022)
    Location: Hall F1
    Abstract Poster Presenter: Taylor Koenig, MD – Cleveland Clinic
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1048: Impact of Hydroxychloroquine Usage on QTc in Veterans with Rheumatic Musculoskeletal Disease
    Location: Hall F1
    Abstract Poster Presenter: Malika Ibrahim, MD, MRCP – UCLA
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1040: Impact of Clinical Pharmacist-Directed Patient Education on Medication Adherence and Clinical Outcomes in Patients with Inflammatory Arthritis
    Location: Hall F1
    Abstract Poster Presenter: Cristina Hurley, MD (she/her/hers) – Virginia Tech Carilion SOM, Carilion Clinic
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1043: The Care Pathway and Treatment Patterns in Patients with Uncontrolled Gout: A Real-World Survey of Physicians In The United States
    Location: Hall F1
    Abstract Poster Presenter: Gordon Lam, MD, FACR – Arthritis & Osteoporosis Consultants of the Carolinas
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1047: Primary Care Perspectives on Giant Cell Arteritis: Diagnostic Considerations, Referral Challenges, and Opportunities for Fast-Track Pathways in the U.S.
    Location: Hall F1
    Abstract Poster Presenter: Jon Golenbiewski, DO – Wake Forest University School of Medicine
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1041: Associated Factors and Direct Cost Analysis of Dose Reduction and Discontinuation of Biological Therapies in Rheumatoid Arthritis and Spondyloarthritis: Findings from a Colombian Cohort Within the Framework of an Integrated Management Model
    Location: Hall F1
    Abstract Poster Presenter: Edwin Jauregui, MD – Riesgo de fractura S.A
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1042: Biosimilar adalimumab prescriptions increase before the CVS formulary change and decrease after
    Location: Hall F1
    Abstract Poster Presenter: Eric Roberts, PhD, MPH – University of California, San Francisco
  • Monday, Oct 27th
    1:00 PM - 2:30 PM Central Time
    27M37: Abstracts: Health Services Research
    Location: W190A-B
    Abstract Moderator: Mary Beth Son, MD – Boston Children's Hospital
    Abstract Moderator: Aileen Davis, PhD – University of Toronto
     CE: 0.00
  • Monday, Oct 27th
    1:00 PM - 1:15 PM Central Time
    1656: Risk of Serious Infection associated with non-TNF biologic initiation after Anti-TNF Use in Older Adults with Rheumatoid Arthritis
    Location: W190A-B
    Presenting Author: Jiha Lee, MD, MHS – University of Michigan
  • Monday, Oct 27th
    1:15 PM - 1:30 PM Central Time
    1657: Extracting TNF Inhibitor Switching Reasons and Trajectories From Real-World Data Using Large Language Models
    Location: W190A-B
    Presenting Author: Augusto Garcia-Agundez, PhD – UCSF
  • Monday, Oct 27th
    1:30 PM - 1:45 PM Central Time
    1658: Cardiovascular Disease Risk and Risk Calculator Performance in Rheumatoid Arthritis-Associated Interstitial Lung Disease
    Location: W190A-B
    Presenting Author: Omair Khan, MBBS – University of Nebraska Medical Center (UNMC)
  • Monday, Oct 27th
    1:45 PM - 2:00 PM Central Time
    1659: Prevalence and Progression of Multimorbidity in Rheumatoid Arthritis-Associated Interstitial Lung Disease
    Location: W190A-B
    Presenting Author: James Fagerland, MD – University of Nebraska Medical Center
  • Monday, Oct 27th
    2:00 PM - 2:15 PM Central Time
    1660: Digital Psychological Support for Inflammatory Rheumatic Diseases: A Randomized Clinical Trial
    Location: W190A-B
    Presenting Author: Johannes Knitza, MD – University Marburg
  • Monday, Oct 27th
    2:15 PM - 2:30 PM Central Time
    1661: Artificial Intelligence Applied to Patient Reported Outcomes and Passive Physiologic Sensor Data Can Accurately Classify Low Disease Activity in Rheumatoid Arthritis Patients
    Location: W190A-B
    Presenting Author: Jeffrey Curtis, MD, MS, MPH – University of Alabama at Birmingham
  • Tuesday, Oct 28th
    10:00 AM - 11:30 AM Central Time
    28T20: Cutting Through the Fog: Understanding Cognitive Dysfunction in Rheumatic Diseases
    Location: W184B-C
    Moderator: Louise Thoma, PhD, DPT – University of North Carolina
    Session Coordinator: Matthew Bunyard, MD, RhMSUS – Cleveland Clinic
     CE: 1.50
  • Tuesday, Oct 28th
    10:00 AM - 10:10 AM Central Time
    Brain Fog: The Patient’s Perspective
    Location: W184B-C
    Speaker: Mary Alore, MBA – Michigan Medicine
  • Tuesday, Oct 28th
    10:10 AM - 10:30 AM Central Time
    Conceptual Domains of Cognitive Dysfunction and Their Manifestation in the Daily Lives of People with Fibromyalgia
    Location: W184B-C
    Speaker: Daniel Whibley, PhD – University of Michigan
  • Tuesday, Oct 28th
    10:30 AM - 11:00 AM Central Time
    Cognitive Dysfunction in Inflammatory Arthritis: What Do We Know from People with Rheumatoid Arthritis?
    Location: W184B-C
    Speaker: Patti Katz, PhD – UCSF
  • Tuesday, Oct 28th
    11:00 AM - 11:30 AM Central Time
    Brain Fog: Myth or Reality? Insights from Scleroderma Warriors and Strategies for Staying Sharp
    Location: W184B-C
    Speaker: Yen Chen, PhD (she/her/hers) – University of Michigan
  • Tuesday, Oct 28th
    10:30 AM - 11:30 AM Central Time
    28T30: Ouch! What's New in Pain?
    Location: W375A
    Moderator: Jason Liebowitz, MD – Columbia University Medical Center
    Moderator: Abin Puravath, MD – Cedars-Sinai
    Session Coordinator: Eric Dein, MD, RhMSUS – Institute of Rheumatic and Autoimmune Diseases, Overlook Hospital
     CE: 1.00
  • Tuesday, Oct 28th
    10:30 AM - 11:00 AM Central Time
    Where Is Fibromyalgia in 2025?
    Location: W375A
    Speaker: Michael Kaplan, MD – Icahn School of Medicine at Mount Sinai
  • Tuesday, Oct 28th
    11:00 AM - 11:30 AM Central Time
    What's New in the Pharmacologic Treatment of Pain?
    Location: W375A
    Speaker: Yvonne Lee, MD, MMSc – Northwestern University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    Epidemiology & Public Health Poster III
    Location: Hall F1
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    Health Services Research Poster III
    Location: Hall F1
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    Measures & Measurement of Healthcare Quality Poster II
    Location: Hall F1
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1877: Demographics and trends of Inflammatory Arthritis-Related Mortality in the United States, 1999–2019
    Location: Hall F1
    Abstract Poster Presenter: Aishwarya Sudheer, MD – Saint Vincent Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1878: Customized Therapy for SLE: How Disease Severity Influences the Use of Corticosteroids and Biologics in Patients with SLE in the Lupus Federated Data Network (LupusNet) and a US Claims Database
    Location: Hall F1
    Abstract Poster Presenter: Ashley Orillion, PhD,MS – Johnson & Johnson
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1879: Infections in Hospitalized Patients With and Without Psoriatic Arthritis (2016–2021): A National Inpatient Sample Study
    Location: Hall F1
    Abstract Poster Presenter: AYEMA HAQUE, MD, MBBS (she/her/hers) – Western Michigan University School of Medicine
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1880: Rheumatoid Arthritis Mortality in the U.S. (1999–2020): A Decline in Rates, But Not in Disparities
    Location: Hall F1
    Abstract Poster Presenter: Aziz-ur-Rahman Khalid, DO – St. Joseph’s University Medical Center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1881: Silent Impact: Two Decades of Sjögren’s Syndrome Mortality in the United States
    Location: Hall F1
    Abstract Poster Presenter: Aziz-ur-Rahman Khalid, DO – St. Joseph’s University Medical Center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1882: Vessels Under Fire: National Mortality Trends in Systemic Vasculitides in the United States, 1999–2020
    Location: Hall F1
    Abstract Poster Presenter: Aziz-ur-Rahman Khalid, DO – St. Joseph’s University Medical Center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1883: Temporal Patterns of Cardiometabolic Comorbidities Before and After Psoriatic Arthritis Diagnosis: A Nationwide Retrospective Study from Poland.
    Location: Hall F1
    Abstract Poster Presenter: Bogdan Batko, MD – UAFM
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1884: The Importance of Adherence to Dietary Recommendations for Rheumatoid Arthritis Risk May Be Greater in Younger Individuals – Results from a Nested Case-Control Study
    Location: Hall F1
    Abstract Poster Presenter: Carl Turesson, MD;PhD – Lund University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1885: Sex-specific Associations of Anthropometrics, Smoking and Eduction with the Risk of Rheumatoid Athritis: A Nested Case-Control Study
    Location: Hall F1
    Abstract Poster Presenter: Carl Turesson, MD;PhD – Lund University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1886: Thirty Percent of Older Adults with Rheumatic Disease Receive High-Risk Medication
    Location: Hall F1
    Abstract Poster Presenter: Christine Anastasiou, MD – Stanford University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1887: Incidence, Prevalence and Mortality of Systemic Lupus Erythematosus – A 20-year territory-wide analysis of electronic health records in Hong Kong
    Location: Hall F1
    Abstract Poster Presenter: Danting Zhang, MPH, PhD – The University of Hong Kong
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1888: Developing Machine Learning Algorithm in Electronic Health Record to Accurately Identify Psoriasis Patients
    Location: Hall F1
    Abstract Poster Presenter: Dilli Poudel, MD (he/him/his) – Vanderbilt University Medical Center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1889: Navigating Diagnostic Challenges: Insights into the Patient Journey and Delays in Diagnosing Dermatomyositis from a Real-world Survey in the United States and Europe
    Location: Hall F1
    Abstract Poster Presenter: Esther Yi, MS, PharmD – Pfizer
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1890: Quantifying the Inflammatory Toll: Smoking-Attributable Rheumatoid Arthritis Burden Across the Globe, 1990–2021
    Location: Hall F1
    Abstract Poster Presenter: Eva Kalra, MBBS – Trident Medical Center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1891: Geographic Trends in the Burden of Gout in the United States from 1990 to 2021: A State-Level Analysis of Prevalence, Incidence, and Disability
    Location: Hall F1
    Abstract Poster Presenter: Eva Kalra, MBBS – Trident Medical Center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1892: Impact of Systemic Lupus Erythematosus on In-Hospital Outcomes Following Percutaneous Coronary Intervention: Insights from a 7 year Nationwide Analysis
    Location: Hall F1
    Abstract Poster Presenter: Freya Shah, MD (she/her/hers) – NYMC/Landmark Medical Center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1893: Increased Atrial Fibrillation Risk in Rheumatoid Arthritis: Greater in Seropositive Than Seronegative Patients
    Location: Hall F1
    Abstract Poster Presenter: Hyungjin Kim, MD;PhD – Samsung Medical Center, Sungkyunkwan University School of Medicine
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1894: Opioid Use Disorder Among Patients with Rheumatic Conditions in the All of Us Research Program: A Descriptive Analysis
    Location: Hall F1
    Abstract Poster Presenter: Jacob Riegler, MD, MS, MBA (he/him/his) – Cambridge Health Alliance
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1895: Assessing the Validity of Self-reported Medication Data Through Metabolite Analysis: Data from the Osteoarthritis Initiative
    Location: Hall F1
    Abstract Poster Presenter: Jeffrey Driban, PhD – UMass Chan Medical School
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1896: Electronic Cigarette Use in Association with Risks of Developing Rheumatoid Arthritis or Systemic Lupus Erythematosus in the All of Us Research Program
    Location: Hall F1
    Abstract Poster Presenter: Jeong Yee, PhD,PharmD – Sungkyunkwan University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1897: Changes in SLE Mortality During and After the COVID-19 Pandemic
    Location: Hall F1
    Abstract Poster Presenter: Laura Hernandez, BS – University of California, Los Angeles
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1898: Assessing Representation in a Nation-wide Psoriasis Registry: A Single-institution Comparison
    Location: Hall F1
    Abstract Poster Presenter: Mackenzie Kilton, BS – University of Nebraska Medical Center College of Medicine
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1899: Regional Variability in SLE Damage Accumulation by Disease Activity Across the Lupus Federated Data Network (LupusNet)
    Location: Hall F1
    Abstract Poster Presenter: Manuel Ugarte-Gil, MD, PhD, MSc – Universidad Cientifica del Sur
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1900: Capturing Patient Cohorts: A Temporal Arteritis Classifier
    Location: Hall F1
    Abstract Poster Presenter: Megan Sullivan, MD, RhMSUS – Mayo Clinic Arizona
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1901: Epidemiology of Adult-Onset Still’s Disease in South Korea: A Nationwide Study Using Health Insurance Claims Data
    Location: Hall F1
    Abstract Poster Presenter: Mihye Kwon, MD, PhD (she/her/hers) – Konyang University Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1902: Investigating Factors Associated With Respiratory Syncytial Virus Vaccination and Breakthrough Infection Among Patients With Systemic Autoimmune Rheumatic Diseases
    Location: Hall F1
    Abstract Poster Presenter: Natalie Davis, MSc – Brigham and Women's Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1903: Seasonal and Racial/Ethnic Variation in Achieving Target Uric Acid Levels in Gout Patients on Urate Lowering Therapy in US Veterans in Central California
    Location: Hall F1
    Abstract Poster Presenter: Nidaa Rasheed, MD – UCSF Fresno
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1904: Mapping CTD-ILD in a Spanish Cohort – the NIRRVANA Registry
    Location: Hall F1
    Abstract Poster Presenter: Paula García-Escudero, MD – Hospital Universitario Álava
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1905: Exploring the Association Between Environmental Quality Index and Rheumatoid Arthritis Mortality in the United States
    Location: Hall F1
    Abstract Poster Presenter: Rohan Sharma, Medical Student – UCLA
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1906: The incidence and mortality of connective tissue diseases in England: a population-level cohort study from 2012 to 2023
    Location: Hall F1
    Abstract Poster Presenter: Samir Patel, MBBS – King's College London
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1907: Twenty-Year Trends in the U.S. Burden of Gout: A State-Level Analysis of Disability and Prevalence from 2001 to 2021
    Location: Hall F1
    Abstract Poster Presenter: Shiza Sarfraz, MD – Brody School of Medicine
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1908: Clinical and Imaging Features of Haemochromatosis Arthropathy - a Systematic Literature Review and Meta- Analysis
    Location: Hall F1
    Abstract Poster Presenter: Stephanie Finzel, MD (she/her/hers) – University Medical Center Freiburg
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1909: Trends of venous thromboembolism after total joint replacement in the United Kingdom after the introduction of NICE guidelines.
    Location: Hall F1
    Abstract Poster Presenter: Subhashisa Swain, PT, PhD, MPH – University of Oxford
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1910: Clinical profile and healthcare resource utilization of patients diagnosed with giant cell arteritis or polymyalgia rheumatica in the US: a real-world cohort study using a large database of administrative health claims
    Location: Hall F1
    Abstract Poster Presenter: Valeria Jordan M., MD – Novartis
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1911: Characterizing Psoriasis Patients at Risk for Transition to Psoriatic Arthritis: Early Insights from the STOP PsA At-Risk Cohort
    Location: Hall F1
    Abstract Poster Presenter: Victoria Konzett, MD – Medical University of Vienna
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1912: Cutaneous manifestations of vasculitis: A cross-sectional analysis from an international cohort
    Location: Hall F1
    Abstract Poster Presenter: William Song, MD – Pennsylvania Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1913: Do We Screen For and Do We Miss Antimalarial-Induced Cardiomyopathy (AMIC)? Risk Profiles according to Hydroxychloroquine Exposure Duration
    Location: Hall F1
    Abstract Poster Presenter: Youngmin Kim, MD – Brigham and Women's Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1915: Innovative Clinical Trial Recruitment Approaches in Lupus Research: LuCIN Site Perspectives on Use of Social Media and Artificial Intelligence
    Location: Hall F1
    Abstract Poster Presenter: Brandon Jackson, MPH – Lupus Therapeutics
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1916: Adherence to Cervical Cancer Screening Programs in Women with Systemic Lupus Erythematosus
    Location: Hall F1
    Abstract Poster Presenter: Carmen Lasa Teja, n/a – Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain.
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1917: Characterizing the Frequency and Timing of Changes in Patient-Reported Social Risk Factors among Rheumatology Outpatients
    Location: Hall F1
    Abstract Poster Presenter: Daphne Lew, PhD,MPH – Washington University in St. Louis School of Medicine
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1918: Vigorous Physical Activity in Patients with SLE Was Not Associated with Disease Activity or Socioeconomic and Social Factors
    Location: Hall F1
    Abstract Poster Presenter: Heather Gold, PhD, MA – NYU Grossman School of Medicine
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1919: Financial insecurity and discrimination are associated with patient-reported quality of life in patients with SLE
    Location: Hall F1
    Abstract Poster Presenter: Heather Gold, PhD, MA – NYU Grossman School of Medicine
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1920: Lung Cancer Screening with Rheumatoid Arthritis: A Retrospective Claims Analysis
    Location: Hall F1
    Abstract Poster Presenter: Huifang Lu, MD;PhD – UT MD Anderson Cancer Center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1922: Exploration of patient and clinician perspectives on rehabilitation in contemporary rheumatology care for rheumatoid arthritis: A qualitative study
    Location: Hall F1
    Abstract Poster Presenter: Joel Thompson – University of North Carolina at Chapel Hill
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1923: A Real-World Survey on Physicians Perspectives of Uncontrolled Gout and Gout Management Practices
    Location: Hall F1
    Abstract Poster Presenter: John Botson, MD – Orthopedic Physicians Alaska
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1924: Real-World Treatment Patterns of Patients with Systemic Autoimmune Rheumatic Disease-associated Interstitial Lung Disease After Progression in The United States
    Location: Hall F1
    Abstract Poster Presenter: Joseph Yang, PharmD – Boehringer Ingelheim
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1925: Associations Between representation And quality in Clinical Trials for Systemic Lupus Erythematosus
    Location: Hall F1
    Abstract Poster Presenter: Joshua Skydel, MD – Yale-New Haven Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1927: Development of the PREVAIL model of care: Optimizing feasibility and acceptability for trial implementation
    Location: Hall F1
    Abstract Poster Presenter: Louise Thoma, PhD, DPT – University of North Carolina
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1928: Oral Health in Patients with Rheumatic Diseases: A Pilot Quality Improvement Program
    Location: Hall F1
    Abstract Poster Presenter: Margarita Isabel Alarcón Jarquin, MD (she/her/hers) – Hospital universitario Dr. José Eleuterio González
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1929: Economic Burden of Macrophage Activation Syndrome (MAS) in Patients with Still's Disease (Systemic Juvenile Idiopathic Arthritis (sJIA) and Adult-onset Still’s Disease (AOSD)): Analysis of a US National Administrative Claims Database
    Location: Hall F1
    Abstract Poster Presenter: Michael Marrone, PhD, MPH – Sobi Inc.
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1930: Can a Multinational Awareness Campaign Improve Referral Rates and Reduce Diagnostic Delays in Patients with Chronic Inflammatory Rheumatic Diseases? The Impact of a Prospective Interventional Study
    Location: Hall F1
    Abstract Poster Presenter: Nelly Ziade, MD, PhD, FRCP – Saint-Joseph University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1931: COSMOS Prevalence of aTTP in SLE
    Location: Hall F1
    Abstract Poster Presenter: Nisha Sapkota, MD – One Brooklyn Health- Interfaith Medical Center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1932: Evaluating a Potential Cause of Excess Lung Cancer Mortality in RA: An Analysis of Chest CT Imaging Frequency in RA
    Location: Hall F1
    Abstract Poster Presenter: Rebecca Brooks, MD (she/her/hers) – Mayo Clinic
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1933: Specialist Wound Care Services Provision and Sharp Debridement Practices for Digital Ulcers (DU) Management in Systemic Sclerosis (SSc): An International Survey
    Location: Hall F1
    Abstract Poster Presenter: Rúben Duarte Fernandes, MSc, RN – LIRMM, University of Leeds
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1934: Analysis of the Determinants of Vaccine Acceptance and Hesitancy in Germany: A Mixed-methods Approach Incorporating Health Insurance Data and Qualitative Interviews with Patients and Physicians
    Location: Hall F1
    Abstract Poster Presenter: Uta Kiltz, MD – Rheumazentrum Ruhrgebiet
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1935: Sex-associated disparities in industry payments to US authors in high-impact rheumatology journals correlate with author impact
    Location: Hall F1
    Abstract Poster Presenter: William Stohl, MD, PhD – University of Southern California
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1982: Bridging the Gap in Underserved Care: A Quality Improvement Initiative to Increase Pneumococcal Vaccination Rates in Immunocompromised Rheumatology Patients
    Location: Hall F1
    Abstract Poster Presenter: Kuan-Tung Lin, MD – North East Medical Services
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1980: Improving Vaccination Rates in the Rheumatology Clinic
    Location: Hall F1
    Abstract Poster Presenter: Kajal Patel, DO – Prisma Health Rheumatology Fellowship Program
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1914: Performance Comparison of Artificial Intelligence tools ChatGPT, Bing AI, and Google Bard for Clinical Rheumatology Decision Support: When AI Talks Rheumatology
    Location: Hall F1
    Abstract Poster Presenter: Aakanksha Pitliya, MD (she/her/hers) – Mercy Catholic Medical Center, Darby, PA
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1981: High Patient Satisfaction with a Medication Education Program: Program to Understand Rheumatology Medications with Pharmacist Led Education
    Location: Hall F1
    Abstract Poster Presenter: Kami Roake, PharmD (she/her/hers) – University of Utah
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1973: Evaluating the Impact of Clinical Pharmacist Integration on Patient Care Outcomes in a Private Rheumatology Clinic
    Location: Hall F1
    Abstract Poster Presenter: Brittany Panico, DO – Summit Rheumatology
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1984: Improving Lipid Screening Rates in Rheumatic Disease Patients: An Academic Fellowship Quality Improvement Project
    Location: Hall F1
    Abstract Poster Presenter: Mahnoor Javed, DO – Houston Methodist
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1987: Evaluating User Engagement and Real-World Impact of a PMR-Specific Digital Symptom Assessment Tool: A 12-Month Analysis of PainSpot™
    Location: Hall F1
    Abstract Poster Presenter: Shilpa Venkatachalam, PhD;MPH – Global Healthy Living Foundation
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1979: Utility of ALT/AST and Fibrosis-4 Index (FIB-4) Score in Monitoring Methotrexate Hepatotoxicity in Rheumatologic Disease: A Retrospective Analysis
    Location: Hall F1
    Abstract Poster Presenter: Julia Wajsberg, DO – University Hospitals
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1977: The Westergren Sedimentation Rate: To Be or Not to Be! The Westergren Sedimentation Rate is being “Killed” but has not “Died”.
    Location: Hall F1
    Abstract Poster Presenter: John Goldman, MD, MACR (he/him/his) – Parris and Associates
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1921: Re-escalation of Treatment in Older Adults with Rheumatoid Arthritis After Anti-TNF Therapy De-escalation
    Location: Hall F1
    Abstract Poster Presenter: Jiha Lee, MD, MHS – University of Michigan
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1978: Utilizing a Gap to Target Function in the Pediatric Rheumatology Care and Outcomes Improvement Network Registry Dashboard of Quality Measures
    Location: Hall F1
    Abstract Poster Presenter: Julia Harris, MD – Children's Mercy Kansas City
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1926: Real World  Rate of Efficacy of Adalimumab Biosimilars Following a Mandated Switch in an Academic Medical Center
    Location: Hall F1
    Abstract Poster Presenter: Katharine McCarthy, PharmD – University of Rochester Medical Center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1974: Serial ferritin as a diagnostic surrogate marker in Hemophagocytic Lymphohistiocytosis (HLH), a retrospective single-center study
    Location: Hall F1
    Abstract Poster Presenter: Chen Chao, MD, MBA – Montefiore Medical Center/Albert Einstein College of Medicine
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1975: Baseline QTc Screening and Monitoring Among SARD Patients with High Cardiovascular Risks on Hydroxychloroquine Based on 2021 ACR Consensus: A Quality Improvement Project
    Location: Hall F1
    Abstract Poster Presenter: Cristine Arcilla, MD (she/her/hers) – Lakeland Regional Health
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1988: Advancing Vascular Assessment: Combining NIRS-VOT and Ultrasound-based Brachial Artery Diameter for Improved Diagnostics in Healthy Controls and APS
    Location: Hall F1
    Abstract Poster Presenter: Soongho Park, PhD – NIH
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1989: Moving Out of the Kid’s Rheum: Transitioning Young Adult Patients from Pediatric to Adult Rheumatology Practices
    Location: Hall F1
    Abstract Poster Presenter: Victoria Koenigsberger, BA (she/her/hers) – The Warren Alpert Medical School of Brown University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1983: Documenting Transition: A Review and Intervention to Increase the Receipt of Transition Summary Letters
    Location: Hall F1
    Abstract Poster Presenter: Kyla Blasingame, MD, BA (she/her/hers) – Baylor College of Medicine
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1976: Implementing a Change Package for Depression Screening and Appropriate Response for Children with Rheumatic Disease
    Location: Hall F1
    Abstract Poster Presenter: Emily Vara, DO (she/her/hers) – Medical University of South Carolina
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1985: Identifying Gaps in Documented Contraception Counseling and Gynecology Referrals for Women on Teratogenic DMARDs: A Foundation for EMR-Based Quality Improvement
    Location: Hall F1
    Abstract Poster Presenter: Rachel Galvao, MD – University of Pennsylvania Health System
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1972: Enhancing Patient Safety: Improving Contraceptive Counseling for Patients on Teratogenic Medications in the Rheumatology Clinic
    Location: Hall F1
    Abstract Poster Presenter: Abi Fadairo Azinge, MD, MPH – University of California San Francisco
  • Tuesday, Oct 28th
    1:00 PM - 2:30 PM Central Time
    28T36: Abstracts: Epidemiology & Public Health II
    Location: S105
    Abstract Moderator: Joshua Baker, MD, MS – University of Pennsylvania
    Abstract Moderator: Manuel Ugarte-Gil, MD, PhD, MSc – Universidad Cientifica del Sur
     CE: 0.00
  • Tuesday, Oct 28th
    1:00 PM - 2:30 PM Central Time
    28T45: 2025 Rheumatology Update from the FDA
    Location: W375B
    Moderator: Raj Nair, MD, RhMSUS – Food and Drug Administration
    Moderator: Michael Weisman, MD – Adjunct Professor of Medicine, Stanford University; Distinguished Professor of Medicine Emeritus, David Geffen School of Medicine at UCLA
    Session Coordinator: Gregory Gardner, MD – University of Washington
     CE: 1.50
  • Tuesday, Oct 28th
    1:00 PM - 2:30 PM Central Time
    28T42: RISE Rollout: New Features, What to Expect, and Future Directions with the New Platform
    Location: W185A-D
    Moderator: Deanna Jannat-Khah, MPH, DrPH – Hospital For Special Surgery
    Session Coordinator: Deanna Jannat-Khah, MPH, DrPH – Hospital For Special Surgery
     CE: 1.50
  • Tuesday, Oct 28th
    1:00 PM - 1:15 PM Central Time
    2567: Temporal Trends in Cardiometabolic Multimorbidity Risk in Rheumatoid Arthritis: A National, Matched Cohort Study
    Location: S105
    Presenting Author: Tate Johnson, MD – University of Nebraska Medical Center
  • Tuesday, Oct 28th
    1:00 PM - 1:20 PM Central Time
    Update on New Therapies in Rheumatology
    Location: W375B
  • Tuesday, Oct 28th
    1:00 PM - 1:30 PM Central Time
    Notes from the Field: Experience from a Pilot Site
    Location: W185A-D
    Speaker: Christie Bartels, MD, MS – University of Wisconsin School of Medicine and Public Health
  • Tuesday, Oct 28th
    1:15 PM - 1:30 PM Central Time
    2568: Cardiovascular Risk Prediction in Systemic Lupus Erythematosus: Comparing the PREVENT and SLECRISK Models
    Location: S105
    Presenting Author: Youngmin Kim, MD – Brigham and Women's Hospital
  • Tuesday, Oct 28th
    1:20 PM - 1:40 PM Central Time
    Safety Issues for Therapies in Rheumatology
    Location: W375B
  • Tuesday, Oct 28th
    1:30 PM - 1:45 PM Central Time
    2569: Performance of the PREVENT Heart Failure General Population Risk Score in Patients with Rheumatoid Arthritis
    Location: S105
    Presenting Author: Ilana Usiskin, MD – Brigham and Women's Hospital
  • Tuesday, Oct 28th
    1:30 PM - 2:00 PM Central Time
    Easily Reporting MVPs and MIPS Using the New Platform
    Location: W185A-D
    Speaker: Thomas Tack, BS – American College of Rheumatology
  • Tuesday, Oct 28th
    1:40 PM - 1:55 PM Central Time
    The FDA and CAT- T Therapies
    Location: W375B
    Speaker: Anam Tariq
  • Tuesday, Oct 28th
    1:45 PM - 2:00 PM Central Time
    2570: Accelerometer-derived ‘weekend Warrior’ Physical Activity, Genetic Susceptibility, and Incident Rheumatoid Arthritis: A Prospective Cohort Study
    Location: S105
    Presenting Author: Zhixiu Li, n/a – Southern University of Science and Technology
  • Tuesday, Oct 28th
    1:55 PM - 2:10 PM Central Time
    The FDA and Multi-Specific Immune Therapies
    Location: W375B
  • Tuesday, Oct 28th
    2:00 PM - 2:15 PM Central Time
    2571: Rare Clinically Significant Methotrexate Toxicity Despite Frequent Laboratory Abnormalities: A Population-Based Study of Methotrexate Monitoring
    Location: S105
    Presenting Author: Griffin Reed, MD – Mayo Clinic
  • Tuesday, Oct 28th
    2:00 PM - 2:30 PM Central Time
    Introduction to the New Platform: Demonstration of Dashboards, Trends, Customizing Local Quality Improvement Measures, and Other Useful Features
    Location: W185A-D
    Speaker: David Voccola, -None- – IQVIA
  • Tuesday, Oct 28th
    2:10 PM - 2:30 PM Central Time
    FDA Update Panel Discussion
    Location: W375B
  • Tuesday, Oct 28th
    2:15 PM - 2:30 PM Central Time
    2572: Multi-Modal Machine Learning Prediction and Phenotyping of Systemic Lupus Erythematosus Using Longitudinal EHR and Genomic Data from the All of Us Program
    Location: S105
    Presenting Author: Hunter Sporn, MS – MIT
  • Tuesday, Oct 28th
    3:00 PM - 4:30 PM Central Time
    28T59: Abstracts: Measures & Measurement of Healthcare Quality
    Location: S103
    Abstract Moderator: Jessica Widdifield, PhD – Sunnybrook Research Institute
    Abstract Moderator: Christie Bartels, MD, MS – University of Wisconsin School of Medicine and Public Health
     CE: 0.00
  • Tuesday, Oct 28th
    3:00 PM - 3:15 PM Central Time
    2615: The Cost of Complexity: Financial Toxicity in Rheumatic Disease, Cancer, and Their Intersection
    Location: S103
    Presenting Author: Manush Sondhi, MD (he/him/his) – University of Washington
  • Tuesday, Oct 28th
    3:15 PM - 3:30 PM Central Time
    2616: Real-World Implication of Clinical Disease Activity Index (CDAI) Utilization on Treatment Decisions and Clinical Outcomes in Rheumatoid Arthritis
    Location: S103
    Presenting Author: Ryan Clark, PharmD – University of North Carolina at Chapel Hill
  • Tuesday, Oct 28th
    3:30 PM - 3:45 PM Central Time
    2617: Design and Initial Results from a Cluster Randomized Trial of a Provider-Facing Immunization Dashboard to Improve Shingrix Vaccination in the Veterans Health Administration
    Location: S103
    Presenting Author: Gabby Schmajuk, MD, MS – UCSF / SFVA
  • Tuesday, Oct 28th
    3:45 PM - 4:00 PM Central Time
    2618: Effect of Implementing a Dashboard with or without a Best Practice Alert on HLA-B*58:01 Testing Rates among Allopurinol Users at VA Medical Centers
    Location: S103
    Presenting Author: Abi Fadairo Azinge, MD, MPH – University of California San Francisco
  • Tuesday, Oct 28th
    4:00 PM - 4:15 PM Central Time
    2619: What Works? A Consolidated Framework for Implementation Research-Guided Exploration of Patient Safety in Rheumatology Practices
    Location: S103
    Presenting Author: Catherine Nasrallah, MPH, BS (she/her/hers) – University of California San Francisco
  • Tuesday, Oct 28th
    4:15 PM - 4:30 PM Central Time
    2620: Transition Success of Pediatric Rheumatology Patients: A Novel Scoring System
    Location: S103
    Presenting Author: Kyla Blasingame, MD, BA (she/her/hers) – Baylor College of Medicine
  • Wednesday, Oct 29th
    8:30 AM - 9:00 AM Central Time
    29W04: Pediatric Rheumatology FDA Updates
    Location: W196A-C
    Moderator: Pui Lee, MD, PhD – Boston Children's Hospital
    Session Coordinator: Jessica Neely, MD – UCSF
    Session Coordinator: Pui Lee, MD, PhD – Boston Children's Hospital
     CE: 0.50
  • Wednesday, Oct 29th
    8:30 AM - 9:00 AM Central Time
    FDA Updates on Pediatric Rheumatology
    Location: W196A-C
    Speaker: Emily Gotschlich, MD – Food and Drug Administration, CDER
  • Wednesday, Oct 29th
    11:30 AM - 1:00 PM Central Time
    29W20: Abstracts: Epidemiology & Public Health I
    Location: W184B-C
    Abstract Moderator: Jose A. Gomez-Puerta, MD, PhD, MPH – Hospital Clínic
    Abstract Moderator: Vivian Kawai, MD – University of Alabama at Birmingham
     CE: 0.00
  • Wednesday, Oct 29th
    11:30 AM - 11:45 AM Central Time
    2657: Incidence of Rheumatic Diseases Among Patients Receiving GLP-1 Receptor Agonists: A Comparative Analysis with DPP-4 Inhibitors in a Propensity Score-Matched Cohort
    Location: W184B-C
    Presenting Author: Betul Ibis, MD (she/her/hers) – Mount Auburn Hospital/Harvard Medical School
  • Wednesday, Oct 29th
    11:45 AM - 12:00 PM Central Time
    2658: Risk of Immune-Mediated Inflammatory Diseases and Other Safety Outcomes in Patients with T2DM and Obesity Initiating GLP-1 RA: A Propensity Score-Matched Multi-center Study using the TriNetX Global Network
    Location: W184B-C
    Presenting Author: Hsin-Hua Chen, MD, PhD – Taichung Veterans General Hospital
  • Wednesday, Oct 29th
    12:00 PM - 12:15 PM Central Time
    2659: Sodium-Glucose Cotransporter 2 Inhibitors for the Primary Prevention of Systemic Autoimmune Rheumatic Diseases in Patients with Type 2 Diabetes: A Population-Based Target Trial Emulation
    Location: W184B-C
    Presenting Author: Jamie Chieh Lo, MD – National Taiwan University Hospital
  • Wednesday, Oct 29th
    12:15 PM - 12:30 PM Central Time
    2660: Understanding Gout in Women: Longitudinal Changes in Serum Urate Levels from Pre-menopause through Post-menopause
    Location: W184B-C
    Presenting Author: Shreya Billa, BS (she/her/hers) – Brigham and Women's Hospital and Harvard Medical School
  • Wednesday, Oct 29th
    12:30 PM - 12:45 PM Central Time
    2661: Heterogeneity of RA-ILD by Longitudinal Forced Vital Capacity Measurements Is Associated with Survival and Respiratory Hospitalization
    Location: W184B-C
    Presenting Author: Bryant England, MD, PhD – University of Nebraska Medical Center
  • Wednesday, Oct 29th
    12:45 PM - 1:00 PM Central Time
    2662: Target trial emulation of biologic and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis-associated interstitial lung disease
    Location: W184B-C
    Presenting Author: Gregory McDermott, MD, MPH – Brigham and Women's Hospital